CrushSCI.com
157.3Average days
190.5Median days
44Fastest days
220Longest days
2782025 publications

Paper Review Records

All Paper Review Records

6 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

212 days

Redirecting full-length FLT1 expression towards its soluble isoform by targeting alternative polyadenylation promotes postischaemic angiogenesis

Authors
Maja Bundalo; Sandra Vorlova; Jessica Ulrich; Giuseppe Rizzo; Elke Butt; Hendrik Bartolomaeus; Hla Ali; Ruggero Barbieri; Leon Richter; Leonie Höna; Manuel Egg; Julian Bock; Sarah Schäfer; Núria Amézaga Solé; Annabelle Rosa; Clément Cochain; Andreas Beilhack; Wolfgang Kastenmüller; Erik Henke; Boris V Skryabin; Timofey S Rozhdestvensky; Moritz Wildgruber; Kari Alitalo; Kristina Lorenz; Michaela Kuhn; Alma ZerneckeShow moreShow less
Affiliations
1. Institute of Experimental Biomedicine, University Hospital Würzburg, Josef-Schneider-Str. 2, D16, Würzburg 97080, Germany; 2. Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Str. 9, Würzburg 97078, Germany; 3. PARCC, INSERM, Université Paris Cité, 56 rue Leblanc, 75015 Paris, France; 4. Department of Internal Medicine II, Center for Experimental Molecular Medicine (ZEMM), Zinklesweg 10, University Hospital Würzburg, Würzburg 97078, Germany; 5. Würzburg Institute of Systems Immunology, Max Planck Research Group, Julius-Maximilians University of Würzburg, Versbacher Straße 9, Würzburg 97078, Germany; 6. Institute of Anatomy and Cell Biology, University of Würzburg, Koellikerstraße 6, Würzburg 97070, Germany; 7. Department of Medicine, Core Facility Transgenic Animal and Genetic Engineering Models (TRAM), University of Münster, Von-Esmarch-Straße 56, Münster 48149, Germany; 8. Department of Radiology, University Hospital, LMU Munich, Marchioninistraße 15, Munich 81377, Germany; 9. Wihuri Research Institute, Biomedicum Helsinki, University of Helsinki, Haartmaninkatu 8, Helsinki 00290, Finland; 10. Department of Translational Research, Cardiovascular Pharmacology, Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Bunsen-Kirchhoff-Str. 11, Dortmund 44139, Germany; 11. Institute of Physiology, University of Würzburg, Röntgenring 9, Würzburg 97070, GermanyShow moreShow less
Source PDF DOI Publisher page
44 days

Obicetrapib–ezetimibe combination therapy: a novel oral strategy for enhanced lipid lowering

Authors
Mitra Chitsazan; Mandana Chitsazan; Christopher P CannonShow moreShow less
Affiliations
1. Iran University of Medical Sciences Department of Medicine, , Tehran ,; 2. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine , New Haven, CT ,; 3. Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School , Boston, MA, USAShow moreShow less
Source PDF DOI Publisher page
220 days

Loss of caveolar A1 adenosine receptor signalling blunts anti-adrenergic control in heart failure

Authors
Marta Mazzola; Houcheng Wang; Di Lang; Marina Balycheva; Navneet Bhogal; Jose L Sanchez-Alonso; Ivan Diakonov; Carla Lucarelli; En-Chi Lai; Prakash P Punjabi; Michele Miragoli; Giuseppe Faggian; Alexey V Glukhov; Julia GorelikShow moreShow less
Affiliations
1. National Heart and Lung Institute, Imperial College London, Imperial Centre for Translational and Experimental Medicine, Hammersmith Campus , Du Cane Road, London W12 0NN ,; 2. Department of Surgery, Dentistry, Pediatrics and Gynecology, Devision of Cardiac Surgery, University of Verona, 37129, Verona ,; 3. Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison , Madison, 1111 Highland Ave 8455 WIMR2, Madison, WI 53705 ,; 4. Department of Medicine, University of California San Francisco , 555 Mission Bay Boulevard South, San Francisco, CA ,; 5. Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute, Imperial College London, Hammersmith Campus , Du Cane Road, London W12 0NN ,; 6. Department of Medicine and Surgery, University of Parma , Via Gramsci, 14 - 43124, Parma ,; 7. IRCCS- Humanitas Research Hospital , Rozzano, Via Alessandro Manzoni, 56, 20089, Rozzano, Milan ,Show moreShow less
Source PDF DOI Publisher page
87 days

Associations of the inflammasome-dependent cytokine IL-18 with risk of coronary heart disease

Authors
Harry Björkbacka; Isabel Gonçalves; Gunnar Engström; Alexandru Schiopu; Anna von Sydow; Maria Ryaboshapkina; Vijayalakshmi Varma; Alastair Moss; Angela C Shore; Andrea Natali; Faisel Khan; Jan NilssonShow moreShow less
Affiliations
1. Department of Clinical Sciences Malmö, Lund University ,; 2. Department of Cardiology, Skåne University Hospital , Jan Waldenströms gata 35, 21428 Malmö ,; 3. Department of Translational Medicine, Lund University , Malmö ,; 4. Nicolae Simionescu Institute of Cellular Biology and Pathology , Bucharest ,; 5. Department of Internal Medicine, Skåne University Hospital , Lund ,; 6. AstraZeneca , Mölndal ,; 7. AstraZeneca , Gaithersburg ,; 8. AstraZeneca , Cambridge ,; 9. Diabetes and Vascular Medicine, University of Exeter Medical School and NIHR Exeter Clinical Research Facility , Exeter ,; 10. Department of Clinical and Experimental Medicine, University of Pisa , Pisa ,; 11. Division of Cardiovascular Research, University of Dundee , Dundee ,Show moreShow less
Source PDF DOI Publisher page
171 days

Macrophage recruitment is a hallmark of non-syndromic myxomatous mitral valve disease

Authors
Benjamin Le Vely; Constance Delwarde; Claire Toquet; Pascal Aumond; Nelli Blank-Stein; Emilie Charon; Séverine Rémy; Ignacio Anegon; Veronika A Myasoedova; Vincenza Valerio; Paolo Poggio; Solena Le Scouarnec; Jean-Jacques Schott; Thierry Le Tourneau; Jean Merot; Elvira Mass; Romain CapouladeShow moreShow less
Affiliations
1. CHU Nantes, CNRS, INSERM, l’institut du thorax Nantes Université, , F-44000 Nantes ,; 2. Developmental Biology of the Immune System, Life & Medical Sciences (LIMES) Institute, University of Bonn , 53115 Bonn ,; 3. INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Transgenic Rats ImmunoPhenomic Nantes Université, , F-44000 Nantes ,; 4. Centro Cardiologico Monzino IRCCS , 20138 Milan ,; 5. Department of Biomedical, Surgical and Dental Sciences, University of Milan , 20122 Milan ,Show moreShow less
Source PDF DOI Publisher page
210 days

Association of HDL cholesterol, apolipoprotein AI, and E concentrations with foetal growth and placental insufficiency

Authors
Rikke Mohr Lytsen; Sofie Taageby Nielsen; Nina Strandkjær; Ida Juul Rasmussen; Anne-Sophie Sillesen; Anna Axelsson Raja; R Ottilia Vøgg; Pia R Kamstrup; Kasper Iversen; Henning Bundgaard; Ruth Frikke-SchmidtShow moreShow less
Affiliations
1. Department of Clinical Biochemistry, Copenhagen University Hospital – Rigshospitalet, Copenhagen ,; 2. Department of Cardiology, Copenhagen University Hospital - Herlev-Gentofte, Denmark; 3. Department of Clinical Biochemistry, Copenhagen University Hospital - Herlev-Gentofte, Denmark; 4. Department of Cardiology, Copenhagen University Hospital – Rigshospitalet , Copenhagen, Denmark; 5. Department of Clinical Medicine, University of Copenhagen, Copenhagen ,Show moreShow less
Source PDF DOI Publisher page

FAQ

How long does CARDIOVASCULAR RESEARCH take to review a manuscript?

As of 2026-11-19, CrushSCI has 6 complete review records for CARDIOVASCULAR RESEARCH. The fastest paper went from submission to acceptance in 44 days (Obicetrapib–ezetimibe combination therapy: a novel oral strategy for enhanced lipid lowering, received 2026-01-26, accepted 2026-03-11); the slowest took 220 days. The average is 157.3 days and the median is 190.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.